Predictive Factors of Early, Late and Very Late Atherothrombotic Events in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials

被引：0

作者：

Giustino, Gennaro ^{[1
]}

Salianski, Olga ^{[1
]}

Aquino, Melissa ^{[2
]}

Sartori, Samantha ^{[3
]}

Stefanini, Giulio G. ^{[4
]}

Leon, Martin ^{[5
]}

Stone, Gregg W. ^{[5
,6
]}

Chieffo, Alaide ^{[7
]}

Dangas, George ^{[8
]}

Kandzari, David ^{[9
]}

Weisz, Giora ^{[10
]}

Wijns, William C. ^{[11
]}

Serruys, Patrick W. ^{[12
]}

Itchhaporia, Dipti ^{[13
]}

Mehran, Roxana ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Icahn Med Mt Sinai, New York, NY USA

[3] Mt Sinai Sch Med, New York, NY USA

[4] Humanitas Res Hosp, Milan, Italy

[5] Cardiovasc Res Fdn, New York, NY USA

[6] Columbia Univ, Med Ctr, New York, NY USA

[7] San Raffael Sci Inst, Milan, Italy

[8] Mt Sinai, New York, NY USA

[9] Piedmont Heart Inst, Atlanta, GA USA

[10] Shaare Zedek Med Ctr, Jerusalem, Israel

[11] Cardiovasc Ctr Aalst, Aalst, Belgium

[12] Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands

[13] Hoag Mem Hosp, Newport Beach, CA USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 15期

关键词：

Drug-eluting stent; Predictors; Women;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-578

引用

页码：B234 / B235

页数：2

共 50 条

[31] Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials
Kok, Marlies M.
van der Heijden, Liefke C.
Sen, Hanim
Danse, Peter W.
Lowik, Marije M.
Anthonio, Rutger L.
Louwerenburg, J. W.
de Man, Frits H. A. F.
Linssen, Gerard C. M.
IJzerman, Maarten J.
Doggen, Carine J. M.
Maas, Angela H. E. M.
Mehran, Roxana
von Birgelen, Clemens
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (06) : 553 - 561
[32] Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials
Alfonso, Fernando
Perez-Vizcayno, Maria Jose
del Blanco, Bruno Garcia
Garcia-Touchard, Arturo
Lopez-Minguez, Jose-Ramon
Masotti, Monica
Zueco, Javier
Melgares, Rafael
Mainar, Vicente
Moreno, Raul
Dominguez, Antonio
Sanchis, Juan
Bethencourt, Armando
Moreu, Jose
Cequier, Angel
Marti, Vicens
Otaegui, Imanol
Bastante, Teresa
Gonzalo, Nieves
Jimenez-Quevedo, Pilar
Cardenas, Alberto
Fernandez, Cristina
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (07)
[33] Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Giustino, Gennaro
Melegari, Camilla
Baber, Usman
Sartori, Samantha
Stone, Gregg
Leon, Martin
Kimura, Takeshi
Aquino, Melissa
Farhan, Serdar
Dangas, George
Stefanini, Giulio
Windecker, Stephan
Steg, Philippe Gabriel
Jeger, Raban
Valgimigli, Marco
Kastrati, Adnan
Chieffo, Alaide
Mehran, Roxana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B191 - B191
[34] Very Late Stent Thrombosis with Second Generation Drug Eluting Stents Compared to Bare Metal Stents: Network Meta-Analysis of Randomized Primary Percutaneous Coronary Intervention Trials
Philip, Femi
Stewart, Susan
Southard, Jeffrey A.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (01) : 38 - 48
[35] Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Hemetsberger, Rayyan
Mankerious, Nader
Toelg, Ralph
Abdelghani, Mohammad
Farhan, Serdar
Garcia-Garica, Hector M.
Allali, Abdelhakim
Windecker, Stephan
Lefevre, Thierry
Saito, Shigeru
Kandzari, David
Waksman, Ron
Richardt, Gert
CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (09) : 1278 - 1287
[36] Differential Impact Of Diabetes Mellitus On Safety And Efficacy Of New Versus First Generation Drug-eluting Stents Among Women: A Patient-level Pooled Analysis Of 26 Randomized Trials
Baber, Usman
Stefanini, Giulio G.
Windecker, Stephan
Morice, Marie-Claude
Sartori, Samantha
Leon, Martin
Stone, Gregg W.
Steg, Philippe G.
Chieffo, Alaide
Mehran, Roxana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B73 - B73
[37] Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Rayyan Hemetsberger
Nader Mankerious
Ralph Toelg
Mohammad Abdelghani
Serdar Farhan
Hector M. Garcia-Garica
Abdelhakim Allali
Stephan Windecker
Thierry Lefèvre
Shigeru Saito
David Kandzari
Ron Waksman
Gert Richardt
Clinical Research in Cardiology, 2023, 112 : 1278 - 1287
[38] Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials
Lin, Bei-you
Li, Ping
Wu, Peng
Jiang, Ri-na
Bundhun, Pravesh Kumar
Ahmed, Mohamad Anis
ADVANCES IN THERAPY, 2019, 36 (11) : 3166 - 3173
[39] Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents Analysis From the BIONICS Randomized Trial
Konigstein, Maayan
Ben-Yehuda, Ori
Smits, Pieter C.
Love, Michael P.
Banai, Shmuel
Perlman, Gidon Y.
Golomb, Mordechai
Ozan, Melek Ozgu
Liu, Mengdan
Leon, Martin B.
Stone, Gregg W.
Kandzari, David E.
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (24) : 2467 - 2476
[40] Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials
Bei-you Lin
Ping Li
Peng Wu
Ri-na Jiang
Pravesh Kumar Bundhun
Mohamad Anis Ahmed
Advances in Therapy, 2019, 36 : 3166 - 3173

← 1 2 3 4 5 →